SCHEMBL24169437

SCHEMBL24169437

Bc1cc(C)c(CO)c(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 5/20 0.38
▸ PDE4B Q07343 5/20 0.38
▸ PDE4C Q08493 5/20 0.38
▸ PDE4D Q08499 5/20 0.38
▸ PDE1A P54750 5/20 0.35
▸ PDE1B Q01064 5/20 0.35
▸ PDE3B Q13370 5/20 0.35
▸ PDE1C Q14123 5/20 0.35
▸ PDE3A Q14432 5/20 0.35
▸ PDE5A O76074 4/20 0.35
▸ PDCD1 Q15116 1/20 0.32
▸ CD274 Q9NZQ7 1/20 0.32
▸ AKR1B1 P15121 1/20 0.31
▸ MMP1 P03956 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ DRD1 P21728 1/20 0.31
▸ TAAR1 Q96RJ0 1/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ BRD9 Q9H8M2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1225856 0.80 ACHE (0.46) PDE4APDE4BPDE4CPDE4DPDE1A
SCHEMBL1047858 0.73 ALDH1A1 (0.46) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL31207104 0.73 CYP3A4 (0.56) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL19681303 0.73 ACHE (0.36) CYP3A4TAAR1CA2CA4ACHE
SCHEMBL8130587 0.72 MEN1 (0.47) PDE4APDE4BPDE4CPDE4DPDE1A
SCHEMBL18277345 0.71 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DPDE1A
SCHEMBL18295990 0.71 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DPDE1A
SCHEMBL23783141 0.71 ERN1 (0.44) PDE4APDE4BPDE4CPDE4DCA2
SCHEMBL28596719 0.71 ACHE (0.45) PDE4APDE4BPDE4CPDE4DPDE1A
SCHEMBL31289582 0.70 PDE1A (0.42) PDE4APDE4BPDE4CPDE4DPDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3717471-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES GALAPAGOS NV (BE) 2022-01-05 — — EP disclosed
Send feedback